Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 424B3:募资说明书
Addex Therapeutics | EFFECT:其他
Addex Therapeutics | POS AM:修改注册声明表
Addex Therapeutics | 20-F:年度报告/过渡报告/注册声明
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 424B5:募资说明书
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K/A:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(6.4%),New Enterprise Associates 15, L.P.(6.4%)等
Addex Therapeutics | 424B3:募资说明书
Addex Therapeutics | EFFECT:其他
Addex Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Timothy Mark Dyer(14.16%)
Addex Therapeutics | POS AM:修改注册声明表
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 6-K:外国发行人报告
暂无数据